Latest Investment News

Resonance Health reports record $14.9M cash receipts over 12 months and completes cost-cutting measures while advancing two major pharma clinical trials on schedule.

Pact Group Holdings has announced its intention to voluntarily delist from the ASX, citing a concentrated shareholder base, low liquidity, and high regulatory costs. Shareholder approval will be sought at an extraordinary general meeting in June 2025.

Iondrive Limited confirms strong financial metrics for its proprietary DES battery recycling technology, progressing pilot plant development and divesting exploration assets to sharpen focus on commercialisation.

Fitzroy River Corporation reported steady royalty income for the year ending March 2025, alongside key strategic agreements and a planned capital return, navigating a volatile global energy landscape.

Beach Energy reported steady production and strong financials in Q3 FY25 despite flood disruptions in the Cooper Basin, with key projects advancing and liquidity improving.

ReadCloud reports robust first half FY25 results, driven by a standout 29% revenue increase in its VET-in-Schools segment, alongside positive cash flow and strengthened operating leverage.

Apollo Minerals reports completion of Phase 2 drilling at its Salanie Gold Project with promising high-grade results, alongside strategic funding and ongoing exploration in Gabon, Serbia, and France.

Emyria Limited reports sustained clinical success in its PTSD program, launches a new treatment-resistant depression therapy, and opens a second Empax Centre to meet growing demand. The company is progressing funding discussions with health insurers and government bodies to support expansion.

H&G High Conviction Limited has completed a major asset divestment, distributing over 63 million Hancock & Gore shares to its shareholders and signaling potential delisting and strategic shifts ahead.

Simble Solutions reported a 39% rise in customer cash receipts for Q1 FY25 and strengthened its market position through strategic partnerships and renewable energy initiatives.

GreenHy2 Limited reports a strategic push in Europe with new contracts for its advanced supercapacitor and hydrogen storage technologies, alongside a cash position of $814K and four quarters of funding runway.

LTR Pharma reports strong Q1 2025 progress with FDA pre-IND meeting success, scientific acclaim for SPONTAN’s rapid absorption, and strategic launch of ROXUS to fast-track US market entry.